Top Analyst Drops Stunning Price Target on Eli Lilly Stock
Bernstein just added new fuel to Eli Lilly’s (LLY) endless rally, as the company raised its stock price target to $1,300 from $1,100. For perspective, this is an 18% increase compared to the previous target, although it represents a 21% to 22% advantage compared to Lilly’s current stock price. Analyst Courtney Breen believes Wall Street…